tiprankstipranks

Sharon Mates Insider Profile

4 Followers
Sharon Mates, Chairman & CEO, Director at Intra-Cellular Therapies, holds 1.07M shares in Intra-Cellular Therapies (Ticker: ITCI). Most recently, Sharon Mates Bought $20,020 shares of Intra-Cellular Therapies on Apr 25, 2024 for an estimated value of 345.62K.
tipranks
Sharon Mates

Sharon Mates
Intra-Cellular Therapies (ITCI)
Chairman & CEO, Director

Ranked #17,434 out of 98,624 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+26.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$78M
100.00%
A breakdown of Sharon Mates's holdings

Insider Roles

Intra-Cellular Therapies
(ITCI)
Chairman & CEO, Director
Roles that Sharon Mates holds in companies

Most Profitable Insider Trade

Stock:
Intra-Cellular Therapies
(ITCI)
Rating:Informative Buy
Date:Dec 21, 2020 - Dec 21, 2021
Return:+67.80%
The most profitable trade made by Sharon Mates

Sharon Mates's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Intra-Cellular Therapies
Apr 25, 2024
Chairman & CEO, Director
Informative Buy
345.62K
$78.41M
Success Rate for
ITCI
3 out of 4 profitable transactions on
ITCI
75%
Average Return for
ITCI
Average return per transaction on
ITCI
+26.25%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Sep 09, 2013
Uninformative Buy
-
$19.00
Nov 28, 2014
Uninformative Sell
$516.25K
-
$0.50
Jan 05, 2017
Uninformative Buy
$0.00
-
$0.00
Jan 28, 2020
Uninformative Buy
$0.00
-
$0.00
Dec 21, 2020
Informative Buy
$93.16K
-
$2.74
+67.80%
List of latest transactions for each holding click on a transaction to see Sharon Mates's performance on stock

Sharon Mates insider profile FAQ

What is the percentage of profitable transactions made by Sharon Mates?
The percentage of profitable transactions made by Sharon Mates is 75%.
    What is the average return per transaction made by Sharon Mates?
    The average return per transaction made by Sharon Mates is 26.20%.
      What stocks does Sharon Mates hold?
      Sharon Mates holds: ITCI stocks.
        What was Sharon Mates’s latest transaction?
        Sharon Mates latest transaction was an Informative Buy of $345.62K.
          What was Sharon Mates's most profitable transaction?
          Sharon Mates’s most profitable transaction was an Informative Buy of ITCI stock on December 21, 2020. The return on the trade was 67.80%.
            What is Sharon Mates's role in Intra-Cellular Therapies?
            Sharon Mates's role in Intra-Cellular Therapies is Chairman & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.